J&J's consumer health spinout has a new name, Kenvue, and a modern look for its well-known portfolio of brands including Tylenol and Neutrogena.
September 28, 2022 10:20 AM EDTUpdated 10:41 AM
Pharma
Marketing

J&J de­buts Ken­vue as new name for $15B con­sumer health busi­ness spin­off

Beth Snyder Bulik

Senior Editor

John­son & John­son’s con­sumer health com­pa­ny has a new name, iden­ti­ty and pur­pose. Ken­vue is a com­bi­na­tion of “ken” mean­ing knowl­edge and “vue” a homonym …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times